Promis Neurosciences Inc.

Canada

Commandez votre montre hebdomadaire Promis Neurosciences Inc.
Quantité totale PI 33
Rang # Quantité totale PI 44 354
Note d'activité PI 2/5.0    14
Rang # Activité PI 61 155
Symbole boursier
ISIN CA74346M1095
Capitalisation 25.44M  (CAD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

18 0
6 0
9 0
0
 
Dernier brevet 2025 - Immunogenic compositions for syn...
Premier brevet 2003 - Epitope protection assay

Derniers inventions, produits et services

2025 Invention Conformation-specific epitopes in alpha-synuclein, antibodies thereto and methods related thereof...
Invention Immunogenic compositions for synucleinopathies. This disclosure pertains to combinations of immun...
Invention Antibodies to amyloid beta. The disclosure pertains to antibodies that bind A-beta oligomers and...
2021 Invention Single chain antibodies and intrabodies to misfolded tdp-43 and methods of use. The disclosure p...
Invention Single chain antibodies and intrabodies to misfolded tdp-43 and methods of use. The disclosure pe...
Invention Antibodies to misfolded amyloid beta. The disclosure pertains to antibodies that bind A-beta oli...
Invention Antibodies to misfolded amyloid beta. The disclosure pertains to antibodies that bind A-beta olig...
2020 Invention Conformation-specific epitopes in tau, antibodies thereto and methods related thereof. The discl...
Invention Conformation-specific epitopes in tau, antibodies thereto and methods related thereof. The disclo...
2019 Invention Antibodies to misfolded tdp-43 and methods of use. The disclosure pertains to antibodies that sp...
Invention Antibodies to misfolded tdp-43 and methods of use. The disclosure pertains to antibodies that spe...
2018 Invention Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide. The disclosure pertains to...
Invention Humanized antibodies binding to amyloid-beta (a-beta). The disclosure pertains to antibodies that...
Invention Antibodies to amyloid beta. The disclosure pertains to antibodies that bind A-beta oligomers and ...
2017 Invention Methods of reducing toxicity induced by amyloid beta (a-beta) oligomers using antibodies specific...
Invention Methods and compositions to treat and detect misfolded-sod1 mediated diseases. The invention pro...
Invention Methods of diagnosing als. The invention relates to an epitope protection assay for use in diagn...
2014 Invention Methods of diagnosing als. The invention relates to an epitope protection assay for use in diagno...
Invention Methods and compositions to treat and detect misfolded-sod1 mediated diseases. The invention prov...
Invention Fasr antibodies for diagnostic and therapeutic use. Provided herein are an exogenous antibody tha...
2013 Invention Antibodies and conjugates that target misfolded prion protein. Human prion protein, PrP, selectiv...
2010 Invention Detection of pathogenic abeta using an epitope protection assay. The invention relates to an epit...
Invention Methods and compositions for detecting amyotrophic lateral sclerosis. The invention provides bind...
Invention Antibodies that bind als specific epitopes and methods of making. The invention relates to an epi...
2008 Invention Als-specific peptide composition. The invention relates to a composition for eliciting an immune ...
2007 Invention Methods and compositions to treat misfolded-sod1 mediated diseases. The invention provides a meth...
2006 Invention Als-specific peptide composition. The invention relates to an epitope protection assay for use in...
2004 Invention Sod-1 epitopes and antibodies.
The invention relates to an epitope protection assay fo...
2003 Invention Epitope protection assay. The invention relates to an epitope protection assay for use in diagnos...